680 related articles for article (PubMed ID: 32978374)
1. Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?
Rada P; González-Rodríguez Á; García-Monzón C; Valverde ÁM
Cell Death Dis; 2020 Sep; 11(9):802. PubMed ID: 32978374
[TBL] [Abstract][Full Text] [Related]
2. CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis.
Zhao L; Zhang C; Luo X; Wang P; Zhou W; Zhong S; Xie Y; Jiang Y; Yang P; Tang R; Pan Q; Hall AR; Luong TV; Fan J; Varghese Z; Moorhead JF; Pinzani M; Chen Y; Ruan XZ
J Hepatol; 2018 Sep; 69(3):705-717. PubMed ID: 29705240
[TBL] [Abstract][Full Text] [Related]
3. Prolactin improves hepatic steatosis via CD36 pathway.
Zhang P; Ge Z; Wang H; Feng W; Sun X; Chu X; Jiang C; Wang Y; Zhu D; Bi Y
J Hepatol; 2018 Jun; 68(6):1247-1255. PubMed ID: 29452209
[TBL] [Abstract][Full Text] [Related]
4. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C.
Miquilena-Colina ME; Lima-Cabello E; Sánchez-Campos S; García-Mediavilla MV; Fernández-Bermejo M; Lozano-Rodríguez T; Vargas-Castrillón J; Buqué X; Ochoa B; Aspichueta P; González-Gallego J; García-Monzón C
Gut; 2011 Oct; 60(10):1394-402. PubMed ID: 21270117
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-inducible factor 2α drives hepatosteatosis through the fatty acid translocase CD36.
Rey E; Meléndez-Rodríguez F; Marañón P; Gil-Valle M; Carrasco AG; Torres-Capelli M; Chávez S; Del Pozo-Maroto E; Rodríguez de Cía J; Aragonés J; García-Monzón C; González-Rodríguez Á
Liver Int; 2020 Oct; 40(10):2553-2567. PubMed ID: 32432822
[TBL] [Abstract][Full Text] [Related]
6. Hepatic FATP5 expression is associated with histological progression and loss of hepatic fat in NAFLD patients.
Enooku K; Tsutsumi T; Kondo M; Fujiwara N; Sasako T; Shibahara J; Kado A; Okushin K; Fujinaga H; Nakagomi R; Minami T; Sato M; Uchino K; Nakagawa H; Kondo Y; Asaoka Y; Tateishi R; Ueki K; Ikeda H; Yoshida H; Moriya K; Yotsuyanagi H; Kadowaki T; Koike K
J Gastroenterol; 2020 Feb; 55(2):227-243. PubMed ID: 31602526
[TBL] [Abstract][Full Text] [Related]
7. From Non-Alcoholic Fatty Liver to Hepatocellular Carcinoma: A Story of (Mal)Adapted Mitochondria.
Amorim R; Magalhães CC; Borges F; Oliveira PJ; Teixeira J
Biology (Basel); 2023 Apr; 12(4):. PubMed ID: 37106795
[TBL] [Abstract][Full Text] [Related]
8. Decreased PEDF Promotes Hepatic Fatty Acid Uptake and Lipid Droplet Formation in the Pathogenesis of NAFLD.
Huang KT; Chen KD; Hsu LW; Kung CP; Li SR; Chen CC; Chiu KW; Goto S; Chen CL
Nutrients; 2020 Jan; 12(1):. PubMed ID: 31968655
[TBL] [Abstract][Full Text] [Related]
9. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans.
Bai J; Xia M; Xue Y; Ma F; Cui A; Sun Y; Han Y; Xu X; Zhang F; Hu Z; Liu Z; Liu Y; Cai G; Su W; Sun X; Wu H; Yan H; Chang X; Hu X; Bian H; Xia P; Gao J; Li Y; Gao X
EBioMedicine; 2020 Jul; 57():102849. PubMed ID: 32580141
[TBL] [Abstract][Full Text] [Related]
10. The Different Mechanisms of Lipid Accumulation in Hepatocytes Induced by Oleic Acid/Palmitic Acid and High-Fat Diet.
Zhang M; Bai X; Du Q; Xu J; Wang D; Chen L; Dong K; Chen Z; Yang J
Molecules; 2023 Sep; 28(18):. PubMed ID: 37764494
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte-Specific Disruption of CD36 Attenuates Fatty Liver and Improves Insulin Sensitivity in HFD-Fed Mice.
Wilson CG; Tran JL; Erion DM; Vera NB; Febbraio M; Weiss EJ
Endocrinology; 2016 Feb; 157(2):570-85. PubMed ID: 26650570
[TBL] [Abstract][Full Text] [Related]
12. Circulating sCD36 levels in patients with non-alcoholic fatty liver disease and controls.
Heebøll S; Poulsen MK; Ornstrup MJ; Kjær TN; Pedersen SB; Nielsen S; Grønbæk H; Handberg A
Int J Obes (Lond); 2017 Feb; 41(2):262-267. PubMed ID: 27916988
[TBL] [Abstract][Full Text] [Related]
13. Hepatic DKK1-driven steatosis is CD36 dependent.
Yang Z; Huang X; Zhang J; You K; Xiong Y; Fang J; Getachew A; Cheng Z; Yu X; Wang Y; Wu F; Wang N; Feng S; Lin X; Yang F; Chen Y; Wei H; Li YX
Life Sci Alliance; 2023 Jan; 6(1):. PubMed ID: 36410795
[TBL] [Abstract][Full Text] [Related]
14. Biological Mechanisms and Related Natural Inhibitors of CD36 in Nonalcoholic Fatty Liver.
Feng Y; Sun W; Sun F; Yin G; Liang P; Chen S; Liu X; Jiang T; Zhang F
Drug Des Devel Ther; 2022; 16():3829-3845. PubMed ID: 36388082
[TBL] [Abstract][Full Text] [Related]
15. Non-Alcoholic Fatty Liver Disease.
Engin A
Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
[TBL] [Abstract][Full Text] [Related]
16. Intracellular and extracellular miRNome deregulation in cellular models of NAFLD or NASH: Clinical implications.
Di Mauro S; Ragusa M; Urbano F; Filippello A; Di Pino A; Scamporrino A; Pulvirenti A; Ferro A; Rabuazzo AM; Purrello M; Purrello F; Piro S
Nutr Metab Cardiovasc Dis; 2016 Dec; 26(12):1129-1139. PubMed ID: 27756518
[TBL] [Abstract][Full Text] [Related]
17. Loss of GPR40 in LDL receptor-deficient mice exacerbates high-fat diet-induced hyperlipidemia and nonalcoholic steatohepatitis.
Lu Z; Li Y; Li AJ; Syn WK; Wank SA; Lopes-Virella MF; Huang Y
PLoS One; 2022; 17(11):e0277251. PubMed ID: 36331958
[TBL] [Abstract][Full Text] [Related]
18. Natural Product Skatole Ameliorates Lipotoxicity-Induced Multiple Hepatic Damage under Hyperlipidemic Conditions in Hepatocytes.
Hong SH; Hong Y; Lee M; Keum BR; Kim GH
Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986221
[TBL] [Abstract][Full Text] [Related]
19. B-cell lymphoma 6 alleviates nonalcoholic fatty liver disease in mice through suppression of fatty acid transporter CD36.
Zhang H; Li Y; Zhang C; Huang K; Zhao J; Le S; Jiang L; Liu H; Yang P; Xiao X; Yu J; Wu J; Ye P; Xia J
Cell Death Dis; 2022 Apr; 13(4):359. PubMed ID: 35436984
[TBL] [Abstract][Full Text] [Related]
20. Transcription factor SOX2 contributes to nonalcoholic fatty liver disease development by regulating the expression of the fatty acid transporter CD36.
Shen C; Chen JH; Oh HR; Park JH
FEBS Lett; 2021 Oct; 595(19):2493-2503. PubMed ID: 34536973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
